AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + proprietary hiring database

✓Executive contact details included

INDUSTRY FIRST

Norgine Appoints Janneke Van Der Kamp As Chief Executive Officer (CEO)

Oct 02, 2024•11 months ago

Position

Chief Executive Officer

Company

Norgine

Janneke van der Kamp

AmsterdamBiotechnology

Description

Norgine has appointed Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. The current CEO, Chris Bath, has stepped down from his role.

Company Information

Company

Norgine

Location

Amsterdam, North Holland, Netherlands

About

Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century. The Company's extensive European experience, fully integrated infrastructure, and exceptional partnership approach allow it to quickly apply creative solutions to bring patients life-changing medicines that they may not otherwise be able to access. Norgine is proud to have helped 24 million patients around the world in 2021 and generated €505 million in net product sales, representing growth of 10% over 2020. Norgine has a direct presence in 16 European countries, as well as Australia and New Zealand, and employs over 1,500 people. Norgine and the sail logo are trademarks of the Norgine group of companies.

Company News

(10 articles)

Thu, 14 Aug 2025 06:01:00 GMT

Norgine completes acquisition of Theravia - PR Newswire

Tue, 15 Apr 2025 07:00:00 GMT

Norgine on a growth charge again with Theravia takeover deal - pharmaphorum

Tue, 15 Apr 2025 07:00:00 GMT

Norgine strengthens rare disease portfolio with acquisition of Theravia - PR Newswire

Wed, 02 Oct 2024 07:00:00 GMT

Norgine Announces Appointment of New CEO Janneke van der Kamp - PR Newswire UK

Mon, 06 Jan 2025 08:00:00 GMT

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma - PR Newswire

Mon, 13 Jan 2025 08:00:00 GMT

X4 Pharmaceuticals and Norgine Enter into Exclusive - GlobeNewswire

Fri, 27 May 2022 07:00:00 GMT

White & Case Advises Goldman Sachs Asset Management Division on Acquisition of Norgine - White & Case LLP

Fri, 24 Jan 2025 08:00:00 GMT

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe. - PR Newswire

Tue, 01 Dec 2020 08:00:00 GMT

NORGINE B.V. ANNOUNCES NEW EUROPEAN HEALTHCARE SUBSIDIARY - MultiVu

Mon, 11 Sep 2023 07:00:00 GMT

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer - PR Newswire

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months